文献速递腹部技术与安全US

原发性肝淋巴瘤的超声造影特征与常见肝脏恶性肿瘤不同:一项对比研究

Contrast-enhanced Ultrasound Features of Primary Hepatic Lymphoma Are Different From Common Malignant Hepatic Tumors: A Comparative Study.
PubMed 文献 · Ultrasound Med Biol · 2025-06-21

本研究对比了病理证实的原发性肝淋巴瘤(n=26)与肝细胞癌、肝内胆管癌、结直肠癌肝转移(各n=26)的超声及超声造影特征。原发性肝淋巴瘤形态规则比例、血管穿行征比例、动脉期等增强或低增强比例均高于其他组,血清肿瘤标志物升高比例更低。超声造影特征有助于术前无创鉴别原发性肝淋巴瘤与其他肝脏恶性肿瘤。

要点

  • 原发性肝淋巴瘤常规超声形态规则的比例显著高于其他三种肝脏恶性肿瘤(p<0.05)。
  • 超声造影中血管穿行征在原发性肝淋巴瘤的比例显著高于其他三组(p<0.001)。
  • 原发性肝淋巴瘤动脉期等增强或低增强比例显著高于肝细胞癌和结直肠癌肝转移组(p<0.05)。

核心结论

  • 超声造影特征有助于术前无创鉴别原发性肝淋巴瘤与其他肝脏恶性肿瘤。

研究设计与样本

  • 对比研究,纳入病理证实的原发性肝淋巴瘤26例、肝细胞癌26例、肝内胆管癌26例、结直肠癌肝转移26例,比较超声特征与临床数据。

关键影像表现/征象

  • 常规超声上原发性肝淋巴瘤形态规则的概率显著高于其他三组(p<0.05)。
  • 超声造影上原发性肝淋巴瘤血管穿行征的比例显著高于其他三组(p<0.001)。
  • 原发性肝淋巴瘤动脉期等增强或低增强的比例显著高于肝细胞癌组和结直肠癌肝转移组(p<0.05)。
  • 原发性肝淋巴瘤的增强类型与结直肠癌肝转移组不同(p<0.05)。

诊断标准与关键数值

  • 原发性肝淋巴瘤组乳酸脱氢酶升高与其他三组差异显著(p<0.05)。
  • 原发性肝淋巴瘤组乙肝病毒感染概率低于肝细胞癌组(p<0.05)。
  • 原发性肝淋巴瘤组血清肿瘤标志物升高的概率显著低于其他三组(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate and compare the ultrasonic features of primary hepatic lymphoma (PHL) and other common hepatic malignancies, such as hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and colorectal liver metastasis (CRLM).

METHODS: The ultrasound features and clinical data of pathologically proven PHL (n = 26) were compared with HCC (n = 26), intrahepatic cholangiocarcinoma (n = 26), and CRLM (n = 26).

RESULTS: There were significant differences in elevated lactate dehydrogenase levels between the PHL group and the other three groups (p < 0.05). The probability of PHL infection with the hepatitis B virus was lower than that of the HCC groups (p < 0.05). The probability of elevated serum tumor markers in PHL was significantly lower than that in the other three groups (p < 0.05). On conventional ultrasound, the probability of regular morphology in PHL was significantly higher than that in the other three groups (p < 0.05). On contrast-enhanced ultrasound examination, the proportion of vessel penetration signs in PHL was significantly higher than that of the other three groups (p < 0.001). The proportion of PHL with isoenhancement or hypoenhancement in the arterial phase was significantly higher than in the HCC and CRLM groups (p < 0.05). The enhancement type of PHL was different than that of the CRLM group (p < 0.05).

CONCLUSION: Contrast-enhanced ultrasound features are useful in the preoperative and noninvasive differentiation of primary hepatic lymphoma and other malignant hepatic tumors.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Yanni C, Feihang W, Yadan X, et al. Contrast-enhanced Ultrasound Features of Primary Hepatic Lymphoma Are Different From Common Malignant Hepatic Tumors: A Comparative Study. Ultrasound Med Biol. 2025. PMID: 40545380. doi:10.1016/j.ultrasmedbio.2025.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。